For Corporate Purchasing Managers, Technical Directors & Operations Leaders seeking a reliable, cost‑effective API that guarantees high purity, regulatory compliance and rapid scale‑up.
You’re under pressure. Procurement teams in the USA are juggling three relentless forces:
According to a 2025 industry survey by PharmaTech Insights, 37% of U.S. biotech firms delayed clinical trials because of API supply issues. That delay translates into an average **$2.1 million** loss per month.
Imagine the scenario: Your lead scientist orders 500 g of Prim‑O‑glucosylcimifugin for a STAT3 pathway study. The supplier quotes $1,200 / g, promises 30‑day delivery, but the batch arrives 6 weeks late with a purity of 92% instead of the required 99%. Your trial timeline stretches, investors question progress, and you scramble for a backup.
| Parameter | Value | Unit |
|---|---|---|
| Chemical Name | Prim‑O‑glucosylcimifugin | — |
| Molecular Formula | C₁₆H₂₂O₈ | — |
| Molecular Weight | 330.34 | g mol⁻¹ |
| Purity (HPLC) | ≥99.5 | % |
| Appearance | White to off‑white powder | — |
| Solubility | Soluble in DMSO, ethanol, methanol | — |
| Stability | Stable ≥24 months at 25 °C | — |
| Certificate | GMP, FDA, ISO 9001, RoHS | — |
Scenario 1 – Oncology R&D: A U.S. biotech firm needed a JAK2/STAT3 inhibitor to validate a novel CAR‑T cell platform. Our 200 g batch (99.7% purity) arrived in 6 days, enabling a 35% reduction in assay cycle time. The client secured $5 M Series A funding within two months.
Scenario 2 – GMP Manufacturing Scale‑up: A contract manufacturing organization (CMO) required 5 tonnes for a Phase III trial. Leveraging our high‑capacity plant, we delivered 4.8 tonnes within 30 days, meeting FDA’s “critical path” timeline and saving the client an estimated $1.2 million in overtime costs.
Scenario 3 – Custom Salt Form: A European pharma requested a sodium salt to improve aqueous solubility for IV formulation. Our R&D team delivered the custom salt in 3 weeks, with documented >10‑fold solubility increase, leading to a successful IND filing.
We accept orders as low as 1 g for research use. For GMP‑grade production, the MOQ is 500 g, but we can negotiate lower thresholds for strategic partners.
Yes. Our R&D team offers full OEM/ODM services, including salt selection, polymorph screening, and particle‑size optimization. Typical lead time: 3‑4 weeks.
All batches are produced under GMP conditions, with in‑process controls (HPLC, NMR, IR) and a full Certificate of Analysis (CoA). We also retain a reference sample for each lot.
We offer:

All shipments include temperature‑controlled packaging and real‑time tracking.
Absolutely. Each batch comes with a GMP‑compliant CoA, analytical method validation reports, stability data, and a full dossier (DMF‑style) ready for FDA/EMA submissions.
Dedicated account managers, 24/7 technical hotline, free analytical re‑testing for up to 30 days, and a 12‑month warranty on product specifications.
Limited‑time Offer: Order before 31 May 2026 and receive a free 5 g sample (no charge, DDP) plus a 10% discount on the first bulk purchase.
We understand the risk of switching suppliers. That’s why we provide a money‑back guarantee if the batch purity falls below 99% – you pay only for the shipping.
Dr. Alan Moore, Chief Scientific Officer, Genexia Labs (USA) – “The sample quality exceeded our expectations. Purity was 99.8% and the documentation was ready for IND filing. We’ve placed a 2‑tonne order for Phase II.”
Ms. Linda Zhao, Procurement Lead, BioPharma Solutions (Canada) – “Fast shipping and transparent pricing saved us $12 k on freight. The OEM salt variant helped us achieve a 15‑fold solubility boost.”
Mr. James Patel, Operations Manager, MedicoTech (UK) – “Customer service responded within 2 hours on a weekend. The batch arrived on schedule, and the analytical data matched the CoA perfectly.”
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page | All information is provided in compliance with U.S. FDA, EU GMP, and local export regulations.
4. Social Proof – Trusted by Global Leaders
Our client portfolio spans Fortune‑500 pharma, leading CROs, and fast‑growing biotech startups.
Exercise-mimetic-performance-enhancer Eyelash-growth-peptide Ammonium-phosphate CAS-27548-93-2-Sclareolide
Compliance & Certifications: CE, FDA, ISO 9001, GMP, RoHS, HACCP, CB, GS, VDE, SAA